Back to Search
Start Over
MS becomes a treatable disease: 30 years later
- Source :
- Multiple Sclerosis Journal. :135245852311747
- Publication Year :
- 2023
- Publisher :
- SAGE Publications, 2023.
-
Abstract
- 30 years ago the first disease-modifying therapy for relapsing multiple sclerosis was approved for use in the United States and soon thereafter across the globe. Since then the field of MS therapeutics, and studies of immunopathogenesis and genetics, have advanced our understanding of the disease and raised the hope of better addressing the next challenges of treating progressive disease, enhancing repair of the damaged nervous system and, hopefully, of a cure. Thirty years into the MS treatment era, the field continues to debate fundamental aspects of MS, and there exists a widening chasm between the triumphs in relapsing disease and the desolation of MS progression, which remains the principal unmet need. In this Personal Viewpoint, we outline lessons learned from the first era of great therapeutic development, as we look to the future of MS research and therapeutics.
- Subjects :
- Neurology
Neurology (clinical)
Subjects
Details
- ISSN :
- 14770970 and 13524585
- Database :
- OpenAIRE
- Journal :
- Multiple Sclerosis Journal
- Accession number :
- edsair.doi...........ac1e80b8c0b96aa83a4987a482ec13bf